AI Drug Startup Insilico Medicine Reportedly Plans to Relaunch HK IPO w/ US$1B+ Valuation

Retrieved on: 2025-03-12 13:27:39

Tags for this article:

Click the tags to see associated articles and topics

AI Drug Startup Insilico Medicine Reportedly Plans to Relaunch HK IPO w/ US$1B+ Valuation. View article details on hiswai:

Excerpt

Insilico Medicine Inc., an AI-driven drug discovery startup, is contemplating rebooting its Hong Kong IPO plans following a new round of financing ...

Article found on: www.aastocks.com

View Original Article